Recruiting A Study to Compare the Steady-State Bioavailability of Injectable Letrozole SIE and Oral Letrozole in Post-Menopausal Women With Hormone Receptor Positive Early Breast Cancer NCT07401381 Conditions Breast Diseases, Breast Neoplasms, Hormone Receptor Positive Early Breast Cancer, +4 more Locations Hospital Clínico Universitario Virgen de la Arrixaca (Investigational Site number ESP-009) — Murcia, Spain View Trial Details
